MedPath

Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis

Phase 2
Completed
Conditions
Jellyfish Dermatitis
Jellyfish Venoms
Interventions
Drug: Ipomea pes-caprae ointment
Registration Number
NCT00944203
Lead Sponsor
Mahidol University
Brief Summary

This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive standard medical treatment depend on the severity of the disease. The doctor will divide the dermatitis area of each patient into two parts. Ipomea pes-caprae ointment will be applied as an add-on therapy to the "test area", while the ointment will not be applied to the "control area". Patients will be asked to come for follow up 6 times in the 28-days study period. Primary objective is to compare the healing time of dermatitis in both areas.

Detailed Description

The "Test area" and "Control area" are allocated in each participant. We use the Internal Control fashion. The healing time of each area will be collected as an outcome measure.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • clinical diagnosis of jellyfish dermatitis
  • total lesion area is more than 4 square centimeter
Exclusion Criteria
  • expose to jellyfish more than 7 days
  • severe systemic reaction to jellyfish
  • allergy to Ipomea pes-caprae or the component of the ointments

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test AreaIpomea pes-caprae ointmentTest Area = Standard Treatment plus Ipomea pes-caprae oinment
Primary Outcome Measures
NameTimeMethod
Healing time of the Jellyfish dermatitis lesion (days)Follow up to 28 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath